The University of Southern California (USC) received a $124,562 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program. The award supports the development of a highly multiplexed Raman imaging platform for studying the role of the immune system in Alzheimer's disease (AD).
The project aims to create a nanoparticle-based Raman imaging approach capable of simultaneously profiling multiple biomarkers from brain tissue samples of AD patients. This innovative molecular imaging technology will enable improved understanding of brain immunity and facilitate the design of new therapeutic strategies for AD and other neurodegenerative diseases. The 2-year project period runs from January 1, 2025 through December 31, 2026.
Generated 4/1/25, 2:02 AM